Browse EX-10 agreements

**AMENDMENT NO. 3 **

**TO THE **

**2020 EQUITY INCENTIVE PLAN **

This AMENDMENT No. 3 TO 2020 EQUITY INCENTIVE PLAN is made as of March 21, 2025, by BLOSSOMHILL THERAPEUTICS, INC., a Delaware corporation (the “Company”).

**RECITALS **

WHEREAS, 6,537,582 shares of Common Stock of the Company have been reserved for issuance under the 2020 Equity Incentive Plan, as amended by Amendment No. 1, dated as of February 26, 2021, and Amendment No. 2, dated as of July 12, 2023 (the “Plan”);

WHEREAS, to further the growth and success of the Company by providing compensation commensurate with maintaining a competitive position in the market to attract and retain key personnel, the Board and the requisite number of stockholders, having acted by written consent, approved an increase in the aggregate number of shares available for issuance under the Plan to 9,003,346 total shares of Common Stock; and

WHEREAS, all capitalized terms not defined herein shall have the same meanings as set forth in the Plan.

**AGREEMENT **

…

***INDEMNIFICATION AGREEMENT ***

This Indemnification Agreement is dated as of _________, 2026 (this “Agreement”) and is between BlossomHill Therapeutics, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).

Background

The Company believes that in order to attract and retain highly competent persons to serve as directors or in other capacities, including as officers, it must provide such persons with adequate protection through indemnification against the risks of claims and actions against them arising out of their services to and activities on behalf of the Company.

The Company desires and has requested Indemnitee to serve as a director and/or officer of the Company and, in order to induce the Indemnitee to serve in such capacity, the Company is willing to grant the Indemnitee the indemnification provided for herein. Indemnitee is willing to so serve on the basis that such indemnification be provided.

…

**BLOSSOMHILL THERAPEUTICS, INC. **

**2020 EQUITY INCENTIVE PLAN **

**STOCK OPTION GRANT NOTICE **

BlossomHill Therapeutics, Inc. (the “Company”) hereby grants to you an Option (the “Option”) to purchase shares of the Company’s Common Stock under the Company’s 2020 Equity Incentive Plan (the “Plan”). The Option is subject to all the terms and conditions set forth in this Stock Option Grant Notice (this “Grant Notice”), in the Stock Option Agreement and in the Plan, which are attached to and incorporated into this Grant Notice in their entirety.

…

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT entered into as of the 23rd day of June, 2026 (this “RRA”), by and between TRILLIUM PARTNERS LP, a Delaware limited partnership (the “Investor”), and Artificial Intelligence Technology Solutions Inc., a Nevada corporation (the “Company”) is made pursuant to the Equity Purchase Agreement (the “Purchase Agreement”), referenced and incorporated herein. Investor and Company shall be referred to individually as “Party,” or “Parties” collectively. IN CONSIDERATION of the promises, the mutual provisions of this Agreement, and other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, Parties hereto agree as follows:

Article 1. Definitions.

Section 1.1 Defined Terms. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this RRA, the following terms shall have the following meanings:

…

EQUITY PURCHASE AGREEMENT

This EQUITY PURCHASE AGREEMENT entered into as of the 23rd day of June, 2026 (this “Purchase Agreement”), by and between TRILLIUM PARTNERS LP, a Delaware limited partnership (the “Investor”), and Artificial Intelligence Technology Solutions Inc., a Nevada corporation (the “Company”). Investor and Company shall be referred to individually as “Party,” or “Parties” collectively.

WHEREAS, the Parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to Investor, from time to time as provided herein, and Investor shall purchase up to Ten Million and 00/100 Dollars ($10,000,000.00) of the Company’s Common Stock (as defined below); and

WHEREAS, as partial consideration for the Investor’s commitment hereunder, the Company shall issue to Investor an aggregate Five Million (5,000,000) common shares of the Company’s Common Stock (the “Commitment Shares”), issued in two equal tranches:

…

LEASE AGREEMENT

** **

(10800 Galaxie Avenue, Ferndale, MI)**

*** ***

*THIS LEASE is made effective as of March 10, 2021, by and between 10800 Galaxie Ave, LLC (“Landlord”*) and Robotic Assistance Devices, Inc., with an address of 31103 Rancho Viejo Rd., Suite D2114, San Juan Capistrano, CA 92675 (“Tenant”**).

1. PREMISES. Landlord, in consideration of the rents to be paid and the covenants and agreements to be performed by Tenant, does hereby lease unto Tenant the real property containing an approximately 29,316 square foot building (the “Building”) commonly known as 10800 Galaxie Avenue, Ferndale, Michigan 48220, as more particularly depicted on Exhibit A attached hereto (the “Premises”).

…

EXECUTION COPY

July 8, 2026

Mercator Acquisition Corp.

85 Washington Street,

Norwalk, CT 06854

Re: Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Mercator Acquisition Corp., a Cayman Islands exempted company (the “Company”) and Clear Street LLC as representative (the “Representative”) of the underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 28,750,000 of the Company’s units (including up to 3,750,000 units which may be purchased to cover over- allotments, if any) (the “Units”), each comprised of one Class A ordinary share, par value $0.0001 per share, of the Company (the “Class A Ordinary Shares”) and one-third of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject

…

EXECUTION COPY

REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT

** **

THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of July 8, 2026, is made and entered into by and among Mercator Acquisition Corp., a Cayman Islands exempted company (the “Company”), Mercator Investor Holdings, LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

** **

WHEREAS, the Sponsor currently owns 5,750,000 Class B ordinary shares of the Company, par value $0.0001 per share (the “Class B Ordinary Shares”), and the other Holders currently own an aggregate of zero (0) Class B Ordinary Shares, which were received from the Sponsor;

…

EXECUTION COPY

**MERCATOR ACQUISITION CORP. **

85 Washington Street,

Norwalk, CT 06854

July 8, 2026

Mercator Investor Holdings, LLC

85 Washington Street,

Norwalk, CT 06854

Ladies and Gentlemen:

This letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement on Form S-1 (the “Registration Statement”) for the initial public offering (the “IPO”) of the securities of Mercator Acquisition Corp., a Cayman Islands exempted company (the “Company”), and continuing until the earlier of (i) the consummation by the Company of an initial business combination and (ii) the Company’s liquidation (in each case, as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”), Mercator Investor Holdings, LLC, a Delaware limited liability company (the “Sponsor”), shall take steps directly or indirectly to make available to the Company, at 85 Washington Street, Norwalk, CT 06854 (or any successor location), office space and secretarial and admin

…

Exhibit 10.3(a)

EXECUTION COPY

SPONSOR PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

** **

THIS SPONSOR PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of July 8, 2026, is entered into by and between Mercator Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Mercator Investor Holdings, LLC, a Delaware limited liability company (the “Purchaser”).

…

EXECUTION COPY

FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT

** **

THIS INVESTMENT MANAGEMENT TRUST AGREEMENT is made effective as of July 8, 2026 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), by and between Mercator Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

WHEREAS, the Company’s registration statement on Form S-1, File No. 333-293902 (the “Registration Statement”), and prospectus (the “Prospectus”) for the initial public offering (the “Offering”) of the Company’s units (the “Units”), each of which consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share, has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

…

EXECUTION COPY

CONFIDENTIAL

** **

July 8, 2026

Shawn Matthews

Chief Executive Officer

Mercator Acquisition Corp.

85 Washington Street

Norwalk, CT 06854

Re:	Engagement of Services

** **

Dear Mr. Matthews:

This will confirm the basis upon which Mercator Acquisition Corp. (“Client”) has engaged Zenith Securities, LLC (“Zenith”), to provide consulting and advisory services (the “Engagement”) in connection with Client’s special purpose acquisition company ***(“SPAC”) ***initial public offering ***(“IPO”) ***of its securities (the “Transaction”). Such services include:

…